Mirae Asset Global ETFs Holdings
DERM icon

Mirae Asset Global ETFs Holdings’s Journey Medical DERM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.5K Buy
9,695
+3,023
+45% +$23.5K ﹤0.01% 2924
2025
Q4 		$51.4K Buy
6,672
+1,061
+19% +$8.32K ﹤0.01% 2928
2025
Q3 		$40K Sell
5,611
-1,012
-15% -$7.34K ﹤0.01% 2983
2025
Q2 		$47.6K Buy
+6,623
New +$45.8K ﹤0.01% 2891

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DERM Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Journey Medical (DERM) stake by 45% in Q1 2026, buying an estimated $23.5K and bringing the position to 9,695 shares worth $45.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Mirae Asset Global ETFs Holdings first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. The position peaked at $51.4K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 9,695 shares of Journey Medical worth $45.5K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 3,023 Journey Medical shares in Q1 2026, an estimated $23.5K.
  • Journey Medical made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2924 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Journey Medical position peaked at $51.4K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.